Verastem, Inc. ( VSTM) - Stock Earnings

VSTM Quarterly earnings

Analyst consensus estimates are available to paid members.

DateEarningsRevenue
2025Q4 -32.9 million USD 17.5 million USD
2026Q1 -36.6 million USD 18.7 million USD
2026Q2 -34.7 million USD 40.1 million USD
2026Q3 Est.
2026Q4 Est.
2027Q1 Est.

VSTM Yearly earnings

Analyst consensus estimates are available to paid members.

DateEarningsRevenue
2023 -87.4 million USD — USD
2024 -130.6 million USD 10.0 million USD
2025 -209.5 million USD 30.9 million USD
2026 Est.

VSTM

Price: $7.18

52 week price:
3.43
11.25

Earnings Per Share: -2.40 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 245000

Ebitda: -22.9 million

Market Capitalization: 629.4 million

Links: